Trial intelligence / Profile preview

Lubiprostone vs Placebo for Medication-Induced Constipation

NCT01096290Phase 4Terminated

Sponsor
University of South Alabama
Start
Apr 2010
Primary completion
Sep 2012
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in constipation comparing Lubiprostone with Placebo (2 arms). Primary endpoint: Relief of Constipation Defined by Modified ROME Criteria at 30 days. Started Apr 2010; status: terminated.

02

Drugs

cobiprostone
03

Conditions

constipation

Beyond the preview

Go deeper on NCT01096290.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01096290.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call